Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Abstract Background Laryngeal mask airways have been widely used in clinical practice. The aim of this study was to investigate whether the remifentanil requirement for facilitation of i-gel insertion in Parkinson’s disease (PD) patients undergoing deep brain stimulation (DBS) surgery was different...

Full description

Bibliographic Details
Main Authors: Wenjun Meng, Fang Kang, Meirong Dong, Song Wang, Mingming Han, Xiang Huang, Sheng Wang, Juan Li, Chengwei Yang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Anesthesiology
Subjects:
Parkinson’s disease
Pharmacology
Remifentanil
I-gel insertion
Deep brain stimulator implantation
Online Access:https://doi.org/10.1186/s12871-022-01735-0

Internet

https://doi.org/10.1186/s12871-022-01735-0

Similar Items